Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: Androgen deprivation therapy (ADT) is associated with increased fracture risk. In a recent Phase III trial, toremifene significantly decreased vertebral fractures in men receiving ADT. Similar to other selective estrogen receptor modulators, toremifene was associated with an increase in ven...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, Matthew R., Malkowicz, S. Bruce, Brawer, Michael K., Hancock, Michael L., Morton, Ronald A., Steiner, Mitchell S.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671875/
https://ncbi.nlm.nih.gov/pubmed/22014807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2011.07.090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars